-
20/20: Surgery can let you see like a child again
Improvements to cataract surgery and lenses can not only help people see more clearly, but can also help solve their lifelong vision problems and let them ditch their glasses.
-
Which treatment works best? Institute of Medicine outlines top 100 priorities
RTI International executive is part of committee that develops blueprint for medical study needs.
-
Pozen files drug application for its 'purple pill' Nexium combo to combat arthritis
Filing with FDA triggers a $10 million milestone payment to Chapel Hill drug developer from partner AstraZeneca.
-
Study tracks how swine flu spread
In a startling measure of just how widely a new disease can spread, researchers accurately plotted swine flu's course around the world by tracking air travel from Mexico.
-
Two biotech startups receive $50,000 Biotech Center loans
Agile Sciences, NeuroScience Pharmaceuticals are commercializing technology developed at NCSU, Duke.
-
Ovary transplants may help women fight biological clocks
Two new techniques to preserve and transplant ovaries might give women a better chance to fight their biological clocks and have children when they are older, doctors announced Monday.
-
Big vaccine business for GSK, Novartis? Swine ful may require 600 million doses
A potential fall swine flu immunization campaign may involve an unprecedented 600 million doses of vaccine, though officials said Friday they haven't figured out how to administer so many doses or accurately track side effects if a seasonal vaccine is given simultaneously.
-
UNC-CH specialist: Swine flu vaccine availability still unclear
Every flu season a vaccine is available to control the spread of the illness, but the H1N1 virus has been spreading without a vaccine to control it.
-
CDC: U.S. swine ful cases hit 1 million
As many as 1 million Americans now have swine flu, U.S. health officials said Thursday, adding that 6 percent or more of some urban areas are infected. The estimate voiced by a government flu scientist Thursday was no surprise to the experts who have been closely watching the virus.
-
PPD pulls out of N.C. Research Campus, citing slow development of project
Pharmaceutical Product Development had committed to creating 300 jobs at Kannapolis biotech center being built by billionaire David Murdock.
-
Jobs' liver transplant shows power of the rich
A celebrity like Apple CEO Steve Jobs scores a rare organ transplant and the world wonders: Did he game the system? The rich have plenty of advantages that others don't. But winning the "transplant lottery" involves more than the size of your wallet – and true medical need.
-
Stomach stapling may lower cancer risk in women – but not men
Women who have their stomachs stapled not only lose weight; they also may reduce their cancer risk by up to 40 percent, new research says. In a study of more than 2,000 obese people who had surgery to reduce the size of their stomachs, Swedish researchers found women who had the procedure were less likely to get cancer than those who did not.
-
Want to reduce pancreatic cancer risk? Weight control could help
It’s estimated that nearly 27 percent of all cases of this highly lethal cancer are due in part to excess weight.
-
Duke explores alternative to open heart surgery for murmurs
A trial at Duke Hospital is helping people born with a defect in the aortic heart valve correct the problem without several open-heart surgeries.
-
Linking viruses, cancer – A key to developing new treatments?
UniversityTech: The University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer has uncovered clues to the development of cancers in AIDS patients.
-
N.C. Research Campus could land federal research center, hundreds of jobs
U.S. Department of Agriculture might pick Kannapolis for a nutrition and research center. Rep. Larry Kissell is seeking a $500,000 earmark to establish the center.
-
N.C. Biotech Center awards $2.5 million grant to nanobiotechnology center
Center for Innovation in Nanobiotechnology, which is located in the Triad, will receive money over four years. The goal is to help commercialize research done at state’s universities.
-
Oh, what a relief: Bleach baths can give relief from eczema
A weekly bath in bleach can give relief to the millions of American children – one in six – who suffer from the skin affliction called eczema.
-
Quintiles vaults to 16th on '100 Best Places to Work in IT' list
The information technology group at the world's largest privately held contract research organization is "making real contributions," says Quintiles chief information officer. "We make a difference now, and people like that."
-
Novartis just says 'no' to free swine flu vaccine
With swine flu now an official pandemic, the race is on among drugmakers to produce a vaccine. GSK to offer 50M free doses. Novartis won't.
-
Novartis produces first batch of swine flu vaccine; GSK continues research
Swiss pharmaceuticals company Novartis AG said Friday it has successfully produced a first batch of swine flu vaccine weeks ahead of expectations. A plant in Holly Springs is designed to produce new type of treatment.
-
Stemming leukemia: Benefits of treatment may outweigh risks
Researchers reviewed data from two dozen studies on allogeneic stem cell transplantation, in which blood-forming donor cells replace abnormal cells in a patient's bone marrow. The procedure has a high risk of serious side effects.
-
Talecris, Australian firm call off $3.1 billion merger
U.S. government had moved to stop the acquisition of RTP-based Talecris by CSL, saying the resulting company would hurt therapeutics business. Talecris will receive $75 million 'break' fee.
-
New study backs diabetes drug Avandia, GSK says
Drug giant releases results of its own study at diabetes conferencing that it says downplays heart attack risks. WHO, meanwhile, endorses GSK diarrhea drug.
-
Study: Therapy may prevent depression in at-risk teens
When teens become depressed, it can have a ripple effect in their lives, according to psychologist Judy Garber, of Vanderbilt University.
-
New treatments emerge for fatal, common aneurysms
About 200,000 Americans are diagnosed annually with an abdominal aortic aneurysm – a relatively common condition that can be deadly if untreated.
-
FTC clears GSK's $3B buyout of Stiefel Labs
Federal regulators on Tuesday cleared British drugmaker GlaxoSmithKline's $3 billion takeover of U.S. dermatology business Stiefel Laboratories Inc.
-
GlaxoSmithKline strikes potential $1B drug deal with Massachusetts startup
Drug giant will invest $16.7 million in Concert and make another $18.3 million in upfront payments. GSK also agreed to royalties and milestone payments linked to product development.
-
Wisconsin firm wins a bidding war for etrials at $18M; clinical trial firm will remain in Morrisville
Merge Healthcare strikes a deal for electronic clinical trials services provider at $3 million more than recently announced sale to another firm.
-
INC Research to acquire later-phase clinical trials business unit for $50M
Deal adds 800 employees, expands geographic reach of Raleigh-based life sciences services firm.
-
Talecris CEO insists acquisition by Australian firm is 'pro-competitive'
Federal Trade Commission seeks to block $3.1B Talecris-CSL merger. But the top Talecris executive remains committed to deal.
-
'We've really come a long way, baby;' Quintiles dedicates new headquarters
Founder and chairman Dennis Gillings calls opening "a celebration of the grand impact we've had on people's lives." Drug development services firm is world's largest.
-
New level of direction: GPS technology helps brain surgeons
A new tool can help physicians get rid of the guesswork and make more accurate cuts during brain surgery.
-
Australian firm to fight U.S. government for Talecris deal
After Federal Trade Commission files suit to block $3.1 billion takeover of RTP-based therapeutics firm, CSL’s top executive stands firm.
-
UNC Health Care, IBM create a 'data warehouse' for disease research
IBM and UNC Health Care are teaming up to combat diseases with a new data base of patient information that researchers will be able to access much more quickly than through traditional services.
-
Talecris stays mum about possible U.S. government rejection of merger
Australian firm CSL says U.S. Federal Trade Commission is likely to block its proposed $3.1 billion acquisition of rival Talecris Biotherapeutics, which is based in RTP.
-
Video: Researchers to study lymphoma similarities between humans, canines
Dogs may be closer to humans than you may think. At least that is what researchers are trying to determine as they work to improve lymphoma treatment for people.
-
Talecris stays mum about possible U.S. government rejection of merger
Australian firm CSL says U.S. Federal Trade Commission is likely to block its proposed $3.1 billion acquisition of rival Talecris Biotherapeutics, which is based in RTP.
-
Video: First case of swine flu reported in Durham County
Public Health Director Gayle B. Harris announced Saturday afternoon that officials have confirmed Durham County’s first case of swine flu, also known as the H1N1 virus.
-
Video: WRAL's Dr. Mask explains symptoms of H1N1 virus
WRAL's Dr. Allen Mask explains symptoms of H1N1 virus.
-
Video: Breath can be key to weight loss
A breathing test can help people learn how many calories they consume each day and form a plan to lose weight.
-
PPD shares dip as founder and CEO Eshelman changes role
One analyst downgrades the contract research organization’s stock. Another is "perplexed" by the change. Eshelman will become PPD’s executive chairman. A retired Special Forces veteran will become CEO.
-
PPD founder turns over day-to-day operations to Special Forces vet
Fred Eshelman assumes new role as executive chairman of the Wilmington-based contract research organization and life sciences firm. David Grange, a board member since 2003, becomes CEO in management shakeup. PPD’s long-time chairman now lead independent director.
-
Video: Breast cancer treatment in older patients studied
Though young women, like 36-year-old actress Christina Applegate, have become the face for breast cancer awareness, doctors say the average woman with the disease is 63 years old.
-
Bioengineering students hope projects help patients
Bioengineering students at North Carolina State University and the University of North Carolina-Chapel Hill unveiled projects designed to help patients in a show at Research Triangle Park this week.
-
Emory University tech transfer exec takes over as SEBIO leader
Jennifer Moore replaces Stephanie Adams at 10-year-old life sickness organization.
-
Video exclusive: Quintiles CEO discusses long-term strategy
Dennis Gillings, chairman and chief executive of Quintiles Transnational, shares his thoughts on business strategy.
-
Video: Cancer survivor reaches out to others
When a woman is diagnosed with breast cancer, going through treatment can be a lonely experience. However, it may not be so lonely if you knew someone who had been in your shoes.
-
Chapel Hill-based drug startup Cempra Pharmaceuticals raises $46M in financing
Quaker BioVentures leads ‘C’ round in two-year-old firm. Intersouth also participates. Cempra is developing antibiotics, has two candidates in clinical trial development.
-
Video: Heart patients' therapy includes video games
At FirstHealth Moore Regional Hospital in Pinehurst, doctors are using video games and animals to help patients recover from a stroke or heart surgery.
-
Video: Spine fusion offers promise for back pain sufferers
A new type of spine fusion promises a shorter recovery and less scarring for the tens of thousands of Americans who undergo surgery to alleviate lower back pain each year.
-
Swine flu, antivirals and pregnant women – An opportunity to find answers about risks
Opinion: Three experts on women's health suggest simple measures to improve the wellbeing of mothers during a disease outbreak.
-
Video: New drug offers hope for brain cancer victims
A drug recently approved by the Food and Drug Administration could prolong the lives of the nearly 1,000 Americans diagnosed annually with malignant brain tumors, many of whom don't live more than six months.
-
CED’s Medtech conference to highlight emerging medical device industry in N.C.
In a state where biotech dominates life science headlines, device company execs and CED band together to raise the industry profile. They also want other companies to become more aware of N.C.’s advantages as a home for emerging ventures.
-
Cornerstone Therapeutics sells controlling interest to Italian firm in $70M deal
Cary-based pharmaceutical firm acquires rights to sell a respiratory distress drug from Chiesi Farmaceutici, plus $15.5M in cash and first rights on new drugs Chiesi offers in U.S. However, Cornerstone shares take a pummeling, falling 14 percent.
-
Bayer CropScience to add 128 jobs in Morrisville
The state will provide the company with tax incentives towards an expansion of its Morrisville facility.
-
Bayer CropScience to add 128 jobs in Morrisville
North Carolina provides $2.3 million in tax rebates as incentives for $10.2 million expansion. Jobs will pay average of $101,018.
-
Video: Despite assurances, some people steer clear of pork
Public health authorities have stressed that you can't catch swine flu from eating pork; however, some people are still afraid.
-
Gates’ ‘Grand Challenge’ grants fund Duke, Emory projects
Duke scientist pursues eradication of malaria; Emory project focuses on possible vaccine for tuberculosis.
-
Video: CDC confirms swine flu case in N.C.
A resident of Onslow County who recently traveled to Texas is North Carolina's first confirmed case of swine flu, Gov. Beverly Perdue said Sunday.
-
Video: WRAL's Dr. Mask answers swine flu questions
Dr. Allen Mask answers people's questions about the swine flu outbreak.
-
Video: An inside look at the state lab testing for swine flu
North Carolina health investigators have found no sign of the swine flu in 20 suspected cases they've tested, but officials continued Wednesday to gather specimens as the virus spread to other states.
-
Video: Flu won't catch N.C. hospitals off-guard
Area hospitals have stepped up precautions to limit the spread of swine flu and treat any confirmed cases.
-
Video: Duke professor answers swine flu questions
WRAL's David Crabtree interviews Dr. Oren Cohen, a consulting professor of medicine on the infectious diseases faculty at Duke, with your questions about swine flu.
-
Duke research sheds new light on chemotherapy effectiveness
UniversityTech: Light-scattering technology could hold promise for quickly determining chemotherapy’s effectiveness.
-
Video: Wake Forest medical expert explains swine flu
Dr. Christopher A. Ohl, an infectious disease specialist at Wake Forest University Baptist Medical Center, discusses the swine flu outbreak .
-
Video: Clearing up misconceptions about swine flu
State officials say you can keep eating pork and just need to take normal precautions for flu season, even though there might be some cases of swine in North Carolina.
-
Charlotte businessman kicks off cure multiple sclerosis campaign with $1M
Duke scientist will lead collaborative effort at N.C. Research Campus. Partnership hopes to raise $5 million for genetic research campaign.
-
Novartis flu vaccine plant boosts Holly Springs' economy
Holly Springs is getting a economic boost from having the largest bio-manufacturing project in the U.S. under way in the town's back yard.
-
Video: New Novartis vaccine plant protects Holly Springs economy
Holly Springs is getting a economic boost from having the largest bio-manufacturing project in the U.S. under way in the town's back yard.
-
After profit drops, GSK CEO says U.S. operations face more changes
'It is essential that we reconfigure our U.S. business to make sure we have the right resource in the right areas and an overall lower level of infrastructure costs,' Andrew Witty says.
-
An RTP boost: GlaxoSmithKline buys Stiefel Laboratories for $2.9 billion
Florida-based Stiefel operates a research and development lab in RTP. The company is privately held. Its dermatology products generated some $900 million in sales last year.
-
Video: Should the healthy take statins?
New research has found statins could harm people whose cholesterol levels are already low.
-
GlaxoSmithKline buys Stiefel Laboratories for $2.9 billion
Florida-based Stiefel operates a research and development lab in RTP. The company is privately held. Its dermatology products generated some $900 million in sales last year.
-
New giant with Triangle roots to combat HIV - GSK, Pfizer form joint venture
As yet unnamed company will based U.S. operations in RTP where GSK has a long history of AIDS research. Venture will be No. 2 in HIV drug market share from launch.
-
Video: Yes, you can make your house 'green'
HGTV's Jack Thomasson discusses eco-friendly features people can incorporate into their homes.
-
GlaxoSmithKline, Pfizer form new company to fight HIV
GSK will initially own 85% of the joint venture. U.S. headquarters for new venture will be in Triangle.
-
Fasting not a long-term weight-loss strategy, doctors say
Going without solid food over several days or even weeks may help you lose weight in the short term, but, Natalie Newell, a registered dietician with Rex Healthcare said you may end up gaining even more weight back.
-
N.C. Biotech Center picks three firms for salary-paid fellowship program
Applications for post-doctoral candidates to be considered for jobs are due by May 1.
-
New sensor making life easier for Type I diabetics
Type I diabetics can't properly break down sugars in their blood, so they have to monitor blood sugar levels almost 24 hours a day. However, a new device is making it easier to manage the disease.
-
UNC researchers find compound that could stop brain tumors
UniversityTech: Team also discovers a gene mutation that contributes to tumor growth.
-
Video: Pond plant could clean lagoons, boost energy
Duckweed could be the key to cleaning up the approximately 3,000 hog lagoons in the state while also providing an answer to the global energy crisis.
